Autoimmune Polyendocrine Syndromes: Clues to Type 1 Diabetes Pathogenesis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary Autoimmune diseases like type 1 diabetes are complex in their pathogenesis. One approach to improving our understanding of type 1 diabetes is the study of diseases that represent more extreme examples of autoimmunity. Autoimmune polyendocrine syndromes (APS) are relatively rare diseases that often include type 1 diabetes as part of the disease phenotype. Recently there has been tremendous progress in unraveling some of the underlying mechanisms of APS. Here we highlight the APS disorders with the perspective of the clues they can offer to the pathogenesis and treatment of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452 · cited 1×
“One attractive area that should be explored in these subjects is deep sequencing efforts to search for rare variants (rather than common SNP variants) that may be in play in exerting large effects that have not been appreciated (Altshuler et al., 2008).”
BackgroundRare Variants of IFIH1 , a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes
Nejentsev, S., Walker, N., Riches, D., Egholm, M., & Todd, J. A. (2009) · Science · doi:10.1126/science.1167728 · Cited by 958 · cited 1×
“In terms of AIRE and FOXP3, there have been efforts to deep sequence both genes in large collections of subjects with T1D with negative results (Nejentsev et al., 2009).”
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809 · cited 2×
“Second, there has been a large body of data connecting quantitative changes in thymic insulin expression with diabetes genetic risk that maps to the variable number of tandem repeat (VNTR) elements in the human insulin promoter (Chentoufi and Polychronakos, 2002; Pugliese et al., 1997; Vafiadis et al., 1997).”
Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Bacchetta, R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25112 · Cited by 511
Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
Meager, A., Visvalingam, K., Peterson, P., Möll, K., Murumägi, A., Krohn, K., Eskelin, P., Perheentupa, J., Husebye, E., Kadota, Y., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030289 · Cited by 453 · cited 2×
“Type 1 interferon autoantibodies have proven to be particularly useful diagnostic tools to identify these patients because virtually all APS1 patients reveal antibody reactivity to interferon alfa and/or interferon omega subtypes (Meager et al., 2006; Wolff et al., 2007; Zhang et al., 2007).”
Self-citationErichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422 · cited 1×
“Thyroiditis occurs in about 50% of patients with Addison’s, while T1D occurs in about 15% of Addison’s patients (Erichsen et al., 2009).”
BackgroundSelf-citationType 1 diabetes associated autoimmunity: natural history, genetic associations and screening
Barker, J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1679 · Cited by 350
Dendrou, C. A., Plagnol, V., Fung, E., Yang, J. H. M., Downes, K., Cooper, J. D., Nutland, S., Coleman, G., Himsworth, M., Hardy, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.434 · Cited by 274 · cited 1×
“Although expression amounts of CD25 have correlated with genotype (Dendrou et al., 2009), it remains open whether these risk alleles affect Treg cell function or activity.”
Cited by
Oftedal, B. E., Hellesen, A., Erichsen, M. M., Bratland, E., Vardi, A., Perheentupa, J., Kemp, E. H., Fiskerstrand, T., Viken, M. K., Weetman, A. P., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.021 · Cited by 286
Self-citationOral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis
Aggor, F. E. Y., Break, T. J., Trevejo-Nuñez, G., Whibley, N., Coleman, B. M., Bailey, R. D., Kaplan, D. H., Naglik, J. R., Shan, W., Shetty, A. C., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba0570 · Cited by 119
“For example, OPC occurs in patients with autoimmune polyendocrine syndrome type 1 (APS-1), a congenital autoimmune syndrome caused by mutations in AIRE and characterized by circulating auto-antibodies that neutralize not only IL-17A and IL-17F but also IL-22 (16–19).”
BackgroundAntigen Presentation in the Autoimmune Diabetes of the NOD Mouse
Unanue, E. R. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095941 · Cited by 63
Chantzichristos, D., Eliasson, B., & Johannsson, G. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0052 · Cited by 21
Vinci, F., d’Annunzio, G., Napoli, F., Bassi, M., Montobbio, C., Ferrando, G., & Minuto, N. (2021) · Children · doi:10.3390/children8080702 · Cited by 9
“Our patient’s clinical picture was compatible with autoimmune polyendocrine syndrome type 2 (APS 2), or Schmidt’s syndrome [16].”
Background
Metadata
- Authors
- Husebye, E. S., & Anderson, M. S.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 32
- Issue
- 4
- Pages
- 479-487
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2013987979
- Cited by
- 83
- References
- 10
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.